BIIL 284 BS
BIIL 284 BS is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers
Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers
Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects
Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers
Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical Trials (6)
Effect of Different Food Compositions on Bioavailability of BIIL 284 BS in Healthy Male Volunteers
Effect of BIIL 284 BS on the Pharmacokinetics of Theophylline in Healthy Male Volunteers
Study to Evaluate the Effect of Multiple Doses of BIIL 284 BS on the Pharmacokinetics of Prednisone in Healthy Male Subjects
Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers
Effect of BIIL 284 BS on Patients With Chronic Obstructive Pulmonary Disease (COPD)
The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6